Neurology · Hackensack, NJ
NPI
1578513743
Since 2006
Specialty
Neurology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
211 Essex St, 202
Hackensack, NJ, 07601
Phone (201) 488-1515
Groups this clinician bills Medicare through
Medicare paid, 2024
$177K
1,601 services
Medicare patients, 2024
549
Average age 76
Drug cost, 2024
$770K
1,419 prescriptions
Company payments, 2025
$545
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John F Nogueira was code 99214 (office e&m - established), 413 times for 252 patients. In total John F Nogueira billed 1,601 services in 28 codes, and Medicare paid $177K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-09-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 413 | 252 | $101.30 | $42K |
| 95886 Electrical Nerve Conductivity | Office | 215 | 121 | $85.31 | $18K |
| 99205 Office E&M - New | Office | 116 | 116 | $180.40 | $21K |
| 95911 Electrical Nerve Conductivity | Office | 97 | 95 | $185.37 | $18K |
| 99204 Office E&M - New | Office | 93 | 93 | $136.39 | $13K |
| 99213 Office E&M - Established | Office | 88 | 77 | $72.96 | $6,421 |
| 93880 Duplex Scan - Extracranial Arteries | Facility | 74 | 74 | $31.17 | $2,307 |
| 95813 Neurologic | Office | 56 | 55 | $398.93 | $22K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 45 | 45 | $136.21 | $6,129 |
| 93886 Ultrasound - Nonspecific | Office | 44 | 44 | $248.40 | $11K |
| 93886 Ultrasound - Nonspecific | Facility | 32 | 22 | $38.69 | $1,238 |
| 95909 Electrical Nerve Conductivity | Office | 25 | 25 | $113.77 | $2,844 |
| 99215 Office E&M - Established | Office | 17 | 14 | $156.63 | $2,663 |
| 99203 Office E&M - New | Office | 14 | 14 | $89.43 | $1,252 |
By year: 2022 $182K for 2,437 services; 2023 $180K for 3,478 services; 2024 $177K for 1,601 services.
Medicare prescription drug claims, 2024
In 2024, the drug John F Nogueira prescribed most often to Medicare patients was Gabapentin, with 262 prescriptions and refills. In total John F Nogueira wrote 1,419 Medicare prescriptions that cost $770K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 262 | 705 | 92 | $7,062 |
| Donepezil Hcl Generic | 134 | 366 | 49 | $1,806 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 117 | 340 | 37 | $5,224 |
| Duloxetine Hcl Generic | 62 | 142 | 16 | $1,033 |
| Nortriptyline Hcl Generic | 50 | 146 | 17 | $966 |
| Memantine Hcl Er Memantine Hcl | 49 | 131 | 15 | $5,481 |
| Citalopram Hbr Citalopram Hydrobromide | 49 | 140 | 17 | $321 |
| Oxcarbazepine Generic | 30 | 74 | 13 | $1,586 |
| Pregabalin Generic | 30 | 66 | Under 11 | $851 |
| Amantadine Amantadine Hcl | 28 | 76 | 11 | $2,918 |
| Memantine Hcl Generic | 26 | 74 | 12 | $693 |
| Austedo Deutetrabenazine | 23 | 23 | Under 11 | $141K |
| Baclofen Generic | 23 | 41 | Under 11 | $679 |
| Topiramate Generic | 22 | 64 | Under 11 | $289 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 20 | 58 | Under 11 | $578 |
Brand drugs: 123 claims; generic drugs: 1,296 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John F Nogueira $545 ($545 in general payments such as food, travel and fees) from 18 companies. The largest payer was Pfizer Inc. with $60.64.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 3 | $60.64 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $52.18 |
| Abbvie Inc. ABBV | 3 | $50.88 |
| Biogen, Inc. BIIB | 2 | $49.08 |
| UCB, Inc. UCB.BR | 2 | $41.7 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $34.54 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $34.12 |
| SK Life Science, Inc. | 2 | $33.01 |
| Catalyst Pharmaceuticals, Inc. CPRX | 1 | $32.49 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $19.11 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.